← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2012Last known activity
May 10, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03986268Lead sponsorN/AMay 10, 2019
- NCT03986268Reponsible party - principal investigatorN/AMay 10, 2019
- NCT01484574Overall official - principal investigatorPhase 2Jan 1, 2012
Details
- Founded
- London, GB
- Last known activity
- May 10, 2019